The clinical-stage biopharmaceutical company jumped more than 8% after it was upgraded to overweight from neutral by J.P. Morgan Friday. The bank's analyst highlighted opportunities in a later stage blood disease drug and said the asset was underappreciated.Shares of the biotech company dropped more than 15% Friday after reporting disappointing revenue.
Illumina said it sees sales coming in around $835 million for the quarter, versus the $887.9 million in revenue analysts polled by Refinitiv were expecting.The online personal styling service's stock jumped 1% after Goldman Sachs upgraded to buy from neutral. According to the analyst, the company is expected to outperform due to "product innovation, operational efficiencies, and geographic expansion, combined with the increase in retail store closures .
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:
TheEllenShow LoriGreiner IDEA: PET that never DIES‼️‼️Customized PET ALIVE CLONE that make movements like actual PET. Pet device will manipulate PET to walk, bark, sleep, eat, etc just as the “real” PET. patent buymyidea Travel with your PET too‼️‼️
Because they're hanging onto Powells capitulation to lower rates. When not if Recession hits, that bottom for stimulating economy will affect us in profound ways...
Thanks trump 🤣👌
United States United States Latest News, United States United States Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Asia stocks rise, dollar sags as Fed chair sets stage for rate cutAsian stocks rose and the dollar sagged on Thursday after Federal Reserve Chair ... Yuan benchmark here we come. Winter is coming. Moving the goal posts; changing the rules. Typical leftist games.
Source: Reuters - 🏆 2. / 97 Read more »
Asia stocks gain, dollar droops as Fed chair sets stage for rate cutAsian stocks gained and the dollar drooped on Thursday after Federal Reserve Cha...
Source: Reuters - 🏆 2. / 97 Read more »
European stocks set for higher open after Powell hints at Fed rate cutEuropean stocks look set to open higher Thursday morning after U.S. Federal Reserve Chairman Jerome Powell signaled that the central bank could cut interest rates imminently. WE ARE GOING BACK TO GOLD THEY WERE ALWAYS HIGHER
Source: CNBC - 🏆 12. / 72 Read more »
Kidney dialysis stocks soar as investors see Trump executive order as good newsThe details of the proposal for achieving that goal appear to be far less threatening to the major dialysis providers than initially feared by many investors. Wilbur Ross stock picks? Happy for the hope this gives kidney sufferers. Of course, if The Pres's people win their court case, these same sufferers may lose their overall health care plus preexisting conditions protections. Go figure... Nothing says lower health care costs than to see the relevant publicly traded stocks, in this case kidney dialysis, spike up..not - Kidney dialysis stocks soar as investors see Trump executive order as good news
Source: CNBC - 🏆 12. / 72 Read more »
Stocks gain, dollar sags as Fed chief shores up rate cut prospectsWorld stocks rose, global bond yields fell and the dollar weakened after Federal... Why is he cutting rates if the economy is good? Sags? Lol. How do you expect us to relate that. Fraudulent investors, fraudulent Fed.
Source: Reuters - 🏆 2. / 97 Read more »